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Analysing personal data is a privilege requiring researchers to safeguard data and to use 
data wisely. Safeguarding data means protecting the identity of individuals. Using data 
wisely means using, reusing, and sharing data to their maximum potential. More 
researchers should be given safe access to previously collected data from expensive clinical 
trials and laboratory or epidemiological studies. Journal editors therefore increasingly 
require a data sharing statement in published articles.[1] 
Data sharing must, however, be safe, regulated, and in line with current legislation. 
Unfortunately, some journals encourage researchers to post their data openly in 
downloadable files, regardless of whether these are aggregated or individual level data. 
Such practice is potentially challenging to the privacy of individual participants. 
Although sharing biological data such as serum values or RNA expression data in an Excel file 
on a journal website might seem innocuous, such open sharing requires extreme prudence 
from researchers and journal editors. Data on other variables might be necessary to 
replicate the original analyses (eg, age, gender, geographical location, socioeconomic status, 
lifestyle details, comorbidity, and disease). However, these data pose a potential risk of 
backwards identification of specific individuals. Increasingly sophisticated web crawler 
software can find common text or numbers across all published data and domains. The 
larger the number of variables, the greater the risk with modern technology. 
For Europeans, such open data sharing is likely to violate the EU General Data Protection 
Regulation (GDPR) unless data are truly anonymous and therefore not covered by GDPR. 
However, the GDPR definition of anonymous data is stringent. To make pseudonymised 
individual data open and accessible, European researchers would need specific consent 
from participants. The informed consent of most studies currently being analysed do not 
state that the data will be made openly accessible, nor does it explain the risk of backwards 
identification. In addition, the rights for individuals provided by GDPR, such as the right to 
have data erased, must be properly handled. 
Making pseudonymised individual data openly accessible, without careful attention to what 
is being shared, represents a potential threat to the privacy of the individuals whose data 
we all depend on. We therefore ask editors to reconsider their policy on making individual 
level data openly accessible. A data sharing statement should be mandatory and sufficient 
to satisfy the editors' requirements. 
Data sharing through safe depositories with access control[2] is a step in the right direction, 
whereas making sensitive individual data publicly available on a journal's website is not. 
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